Artificial cells, nanomedicine, and biotechnology

Keyphrases

Publications

volume 52, number 1, 2024

Bjorn K Song, Danuel A Carr, Bjorn K Song, William H Nugent
Oxygenation through oral Ox66 in a two-hit rodent model of respiratory distress. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Badriyah Alotaibi, Thanaa A El-Masry, Engy Elekhnawy, Fatma A Mokhtar, Hosam M El-Seadawy, Walaa A Negm
Studying the effects of secondary metabolites isolated from Cycas thouarsii R.Br. leaves on MDA-MB-231 breast cancer cells. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Hao-Ming Zhou, Xin-Yu Yang, Shi-Jun Yue, Wen-Xiao Wang, Qiao Zhang, Ding-Qiao Xu, Jia-Jia Li, Yu-Ping Tang
The identification of metabolites from gut microbiota in coronary heart disease via network pharmacology. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Sujeet Singh, Hemant Arya, Welka Sahu, K Sony Reddy, Surendra Nimesh, Bader Saud Alotaibi, Mohammed Ageeli Hakami, Hassan Hussain Almasoudi, Khater Balatone Gezira Hessien, Mohammad Raghibul Hasan, Summya Rashid, Tarun Kumar Bhatt
Green synthesized silver nanoparticles of Terminalia bellirica leaves extract: synthesis, characterization, in-silico studies, and antimalarial activity. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Agnishwar Girigoswami, Balasubramanian Deepika, Ashok Kumar Pandurangan, Koyeli Girigoswami
Preparation of titanium dioxide nanoparticles from Solanum Tuberosum peel extract and its applications. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
R Devesh Kumar Misra, Aladin M Boriek
Exploring fibroblast interactions on nanocrystalline surfaces in physiological environments through a phenomenological lens. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Amany Belal, Atiah H Almalki, Ahmed A Farghali, Rehab Mahmoud, R R Atta, Abeer Enaiet Allah, Walid Hamdy Hassan, Sangmin Lee, Amna A Kotp, Doaa Essam, Ahmed H E Hassan, Mohammed M Ghoneim, Fatma I Abo El-Ela, Abdalla Abdelwahab
Nitrogen-doped carbon quantum dots as a novel treatment for black fungal bone infections (Mucormycosis): in vitro and in vivo study. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Jun-Song Zhang, Run-Sang Pan, Guo-Lu Li, Jian-Xiang Teng, Hong-Bo Zhao, Chang-Hua Zhou, Ji-Sheng Zhu, Hao Zheng, Xiao-Bin Tian
Comprehensive analysis of anoikis-related genes in diagnosis osteoarthritis: based on machine learning and single-cell RNA sequencing data. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Agnishwar Girigoswami, Balasubramanian Deepika, Ashok Kumar Pandurangan, Koyeli Girigoswami
Preparation of titanium dioxide nanoparticles from Solanum Tuberosum peel extract and its applications. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
M Haripriyaa, K Suthindhiran
Investigation of pharmacokinetics and immunogenicity of magnetosomes. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Ki-Kwang Oh, Sang-Jun Yoon, Seol Hee Song, Jeong Ha Park, Jeong Su Kim, Dong Joon Kim, Ki-Tae Suk
The synchronized feature of Saururus chinensis and gut microbiota against T2DM, NAFLD, obesity and hypertension via integrated pharmacology. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Wandi Li, Lili Yu
Role and therapeutic perspectives of extracellular vesicles derived from liver and adipose tissue in metabolic dysfunction-associated steatotic liver disease. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Badriyah Alotaibi, Engy Elekhnawy, Thanaa A El-Masry, Asmaa Saleh, Manal E Alosaimi, Khalid Nijr Alotaibi, Walaa A Negm
Antibacterial potential of Euphorbia canariensis against Pseudomonas aeruginosa bacteria causing respiratory tract infections. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Congying Wang, Haodong Jiang, Jia Zhu, Yunpeng Jin
A new agent for contrast-enhanced intravascular ultrasound imaging in vitro: polybutylcyanoacrylate nanoparticles with drug-carrying capacity. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Su-Been Lee, Haripriya Gupta, Byeong-Hyun Min, Raja Ganesan, Satya Priya Sharma, Sung-Min Won, Jin-Ju Jeong, Min-Gi Cha, Goo-Hyun Kwon, Min-Kyo Jeong, Ji-Ye Hyun, Jung-A Eom, Hee-Jin Park, Sang-Jun Yoon, Sang Youn Lee, Mi-Ran Choi, Dong Joon Kim, Ki-Kwang Oh, Ki-Tae Suk
A consortium of Hordeum vulgare and gut microbiota against non-alcoholic fatty liver disease via data-driven analysis. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Jun-Song Zhang, Run-Sang Pan, Guo-Lu Li, Jian-Xiang Teng, Hong-Bo Zhao, Chang-Hua Zhou, Ji-Sheng Zhu, Hao Zheng, Xiao-Bin Tian
Comprehensive analysis of anoikis-related genes in diagnosis osteoarthritis: based on machine learning and single-cell RNA sequencing data. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Meghana Kasturi, Kirthanashri S Vasanthan
Harvesting decellularized liver extracellular matrix from rodents for 3D scaffold fabrication. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Amany Belal, Atiah H Almalki, Ahmed A Farghali, Rehab Mahmoud, R R Atta, Abeer Enaiet Allah, Walid Hamdy Hassan, Sangmin Lee, Amna A Kotp, Doaa Essam, Ahmed H E Hassan, Mohammed M Ghoneim, Fatma I Abo El-Ela, Abdalla Abdelwahab
Nitrogen-doped carbon quantum dots as a novel treatment for black fungal bone infections (Mucormycosis): in vitro and in vivo study. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Jia-Qi Liu, Hong-Bing Zhou, Wan-Fu Bai, Jia Wang, Qian Li, Li-Ya Fan, Hong Chang, Song-Li Shi
Assessment of progression of pulmonary fibrosis based on metabonomics and analysis of intestinal microbiota. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Abdul Nasir, Mujeeb Ur Rehman, Tamreez Khan, Mansoor Husn, Manzar Khan, Ahmad Khan, Abdifatah Mohamed Nuh, Wei Jiang, Hafiz Muhammad Umer Farooqi, Qain Bai
Advances in nanotechnology-assisted photodynamic therapy for neurological disorders: a comprehensive review. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Badriyah Alotaibi, Thanaa A El-Masry, Engy Elekhnawy, Fatma A Mokhtar, Hosam M El-Seadawy, Walaa A Negm
Studying the effects of secondary metabolites isolated from Cycas thouarsii R.Br. leaves on MDA-MB-231 breast cancer cells. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
M Haripriyaa, K Suthindhiran
Investigation of pharmacokinetics and immunogenicity of magnetosomes. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Alessandra Gonnelli, Patrizia Sarogni, Noemi Giannini, Stefania Linsalata, Fabio Di Martino, Agata Zamborlin, Valentina Frusca, Maria Laura Ermini, Paola Puccini, Valerio Voliani, Fabiola Paiar
A bioconvergence study on platinum-free concurrent chemoradiotherapy for the treatment of HPV-negative head and neck carcinoma. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Wandi Li, Lili Yu
Role and therapeutic perspectives of extracellular vesicles derived from liver and adipose tissue in metabolic dysfunction-associated steatotic liver disease. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Shantanu Pande
Factors affecting response variables with emphasis on drug release and loading for optimization of liposomes. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Sean Dowd, Catherine Sharo, Osheiza Abdulmalik, Jacob J Elmer
Optimizing the lyophilization of Lumbricus terrestris erythrocruorin. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Lisa Barrett, Karen Coopman
Cell microencapsulation techniques for cancer modelling and drug discovery. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Badriyah Alotaibi, Engy Elekhnawy, Thanaa A El-Masry, Asmaa Saleh, Manal E Alosaimi, Khalid Nijr Alotaibi, Walaa A Negm
Antibacterial potential of Euphorbia canariensis against Pseudomonas aeruginosa bacteria causing respiratory tract infections. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Hanieh Montaseri, Abrahamse Heidi
Targeted photodynamic therapy technique of Janus nanoparticles on breast cancer. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Taotao Yue, Jinpeng Wang, Fang Liu, Pengtao Gong, Jianhua Li, Xichen Zhang, Nan Zhang
The effects of anti-lung cancer in nude mice by a fully human single-chain antibody against associated antigen Ts7TMR between A549 cells and Trichinella spiralis . Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Congying Wang, Haodong Jiang, Jia Zhu, Yunpeng Jin
A new agent for contrast-enhanced intravascular ultrasound imaging in vitro: polybutylcyanoacrylate nanoparticles with drug-carrying capacity. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Congying Wang, Haodong Jiang, Jia Zhu, Yunpeng Jin
A new agent for contrast-enhanced intravascular ultrasound imaging in vitro: polybutylcyanoacrylate nanoparticles with drug-carrying capacity. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
R Devesh Kumar Misra, Aladin M Boriek
Exploring fibroblast interactions on nanocrystalline surfaces in physiological environments through a phenomenological lens. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Nokuphila Winifred Nompumelelo Simelane, Abrahamse Heidi
Actively targeted photodynamic therapy in multicellular colorectal cancer spheroids via functionalised gold nanoparticles. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Fanai Lalsangpuii, Samuel Lalthazuala Rokhum, Fanai Nghakliana, Joseph V L Ruatpuia, Lalchhandami Tochhawng, Amit Kumar Trivedi, Ralte Lalfakzuala, Zothan Siama
Mikania micrantha silver nanoparticles exhibit anticancer activities against human lung adenocarcinoma via caspase-mediated apoptotic cell death. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Fanai Lalsangpuii, Samuel Lalthazuala Rokhum, Fanai Nghakliana, Joseph V L Ruatpuia, Lalchhandami Tochhawng, Amit Kumar Trivedi, Ralte Lalfakzuala, Zothan Siama
Mikania micrantha silver nanoparticles exhibit anticancer activities against human lung adenocarcinoma via caspase-mediated apoptotic cell death. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Bjorn K Song, Danuel A Carr, Bjorn K Song, William H Nugent
Oxygenation through oral Ox66 in a two-hit rodent model of respiratory distress. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Jia-Qi Liu, Hong-Bing Zhou, Wan-Fu Bai, Jia Wang, Qian Li, Li-Ya Fan, Hong Chang, Song-Li Shi
Assessment of progression of pulmonary fibrosis based on metabonomics and analysis of intestinal microbiota. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Bjorn K Song, Danuel A Carr, Bjorn K Song, William H Nugent
Oxygenation through oral Ox66 in a two-hit rodent model of respiratory distress. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Meghana Kasturi, Kirthanashri S Vasanthan
Harvesting decellularized liver extracellular matrix from rodents for 3D scaffold fabrication. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Hao-Ming Zhou, Xin-Yu Yang, Shi-Jun Yue, Wen-Xiao Wang, Qiao Zhang, Ding-Qiao Xu, Jia-Jia Li, Yu-Ping Tang
The identification of metabolites from gut microbiota in coronary heart disease via network pharmacology. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Magdalena J Bigaj-Józefowska, Tomasz Zalewski, Karol Załęski, L Emerson Coy, Marcin Frankowski, Radosław Mrówczyński, Bartosz F Grześkowiak
Three musketeers of PDA-based MRI contrasting and therapy. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Abdul Nasir, Mujeeb Ur Rehman, Tamreez Khan, Mansoor Husn, Manzar Khan, Ahmad Khan, Abdifatah Mohamed Nuh, Wei Jiang, Hafiz Muhammad Umer Farooqi, Qain Bai
Advances in nanotechnology-assisted photodynamic therapy for neurological disorders: a comprehensive review. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Badriyah Alotaibi, Thanaa A El-Masry, Engy Elekhnawy, Fatma A Mokhtar, Hosam M El-Seadawy, Walaa A Negm
Studying the effects of secondary metabolites isolated from Cycas thouarsii R.Br. leaves on MDA-MB-231 breast cancer cells. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Shasha Hao, Huan Wang, Shen Li, Honghui Zhang, Xintong Xie, Jiaxin Liu, Chengmin Yang, Wentao Zhou, Hong Wang
Carbon monoxide polyhemoglobin improves the therapeutic effect and relieves inflammation in the colon tissue of haemorrhagic shock/resuscitation rats. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Taotao Yue, Jinpeng Wang, Fang Liu, Pengtao Gong, Jianhua Li, Xichen Zhang, Nan Zhang
The effects of anti-lung cancer in nude mice by a fully human single-chain antibody against associated antigen Ts7TMR between A549 cells and Trichinella spiralis . Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Lisa Barrett, Karen Coopman
Cell microencapsulation techniques for cancer modelling and drug discovery. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Sean Dowd, Catherine Sharo, Osheiza Abdulmalik, Jacob J Elmer
Optimizing the lyophilization of Lumbricus terrestris erythrocruorin. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Shantanu Pande
Factors affecting response variables with emphasis on drug release and loading for optimization of liposomes. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)
Alessandra Gonnelli, Patrizia Sarogni, Noemi Giannini, Stefania Linsalata, Fabio Di Martino, Agata Zamborlin, Valentina Frusca, Maria Laura Ermini, Paola Puccini, Valerio Voliani, Fabiola Paiar
A bioconvergence study on platinum-free concurrent chemoradiotherapy for the treatment of HPV-negative head and neck carcinoma. Artificial cells, nanomedicine, and biotechnology 52 (1) (2024)